Bile Acids in Inflammatory Bowel Disease: From Pathophysiology to Treatment
Open Access
- 20 December 2024
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 12 (12) , 2910
Abstract
Inflammatory bowel disease (IBD) is a chronic condition that affects about 7 million people worldwide, and new therapies are needed. Understanding the complex roles that bile acids (BAs) play in IBD may lead to the development of novel IBD treatments independent of direct immunosuppression. This review discusses the latest discoveries in the roles BAs play in IBD pathogenesis and explores how these discoveries offer promising new therapeutic targets to treat IBD and improve patient outcomes. Several therapies discussed include specific BA receptor (BAR) agonists, dietary therapies, supplements, probiotics, and mesenchymal stem cell therapies that have all been shown to decrease IBD disease activity.Keywords
Funding Information
- Crohn's and Colitis Foundation (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
- NIH/NIDDK K08 Clinical Investigator Award (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
- NIH T32 Institutional Research Training Grant (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
- American Gastroenterological Association (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
- Digestive Disease Research Core Center (DDRCC) Pilot and Feasibility Award (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
- Doris Duke COVID-19 Fund to Retain Clinical Scientists Program (CFRCS), Lawrence C. Pakula, MD IBD Education & Innovation Fund (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
- Washington University Clinical and Translational Research Funding Program (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
- Washington University Precision Health Innovation Award (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
- Washington University DDRCC (CCF1062472, 1K08DK140612-01, AGA2023-32-03, P30 DK052574, IA-2022-IBD-1, CTRFP1714, PHIA 101, NIDDK P30 DK052574)
This publication has 231 references indexed in Scilit:
- Bifidobacterium pseudolongum‐Derived Bile Acid from Dietary Carvacrol and Thymol Supplementation Attenuates Colitis via cGMP‐PKG‐mTORC1 PathwayAdvanced Science, 2024
- Gut Epithelial Barrier Function is Impacted by Hyperglycemia and Secondary Bile Acids in Vitro: Possible Rescuing Effects of Specific PectinsMolecular Nutrition & Food Research, 2024
- Bile acid‐activated receptors in innate and adaptive immunity: targeted drugs and biological agentsEuropean Journal of Immunology, 2023
- Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolismJournal of Periodontology, 2022
- Nigakinone alleviates DSS‐induced experimental colitis via regulating bile acid profile and FXR/NLRP3 signaling pathwaysPhytotherapy Research, 2022
- Increased Fecal Bile Acid Excretion in a Significant Subset of Patients with Other Inflammatory Diarrheal DiseasesDigestive Diseases and Sciences, 2021
- Bile Acid Signaling in Inflammatory Bowel DiseasesDigestive Diseases and Sciences, 2020
- Apple polyphenols extract alleviated dextran sulfate sodium‐induced ulcerative colitis in C57BL/6 male mice by restoring bile acid metabolism disorder and gut microbiota dysbiosisPhytotherapy Research, 2020
- Evaluation of the effect of Dahuang–Mudan decoction on TNBS‐induced colitis using UPLC–QTOF/MS‐based metabolomic analysisBiomedical Chromatography, 2020
- Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal InflammationDigestive Diseases and Sciences, 2020